Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 janv. 2023 09h00 HE | Source: Visiongain Reports Ltd

Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd

Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
28 nov. 2022 12h08 HE | Source: Visiongain Reports Ltd

Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd

Visiongain has published a new report entitled Macular Degeneration (AMD) and Other Retinal Diseases Drugs 2022-2032. It includes profiles of Macular Degeneration (AMD) and Other Retinal Diseases...
07 avr. 2022 09h00 HE | Source: Visiongain Ltd

Global Macular Degeneration (AMD) and other retinal diseases drugs market is projected to reach at a market value of US$ 40.16 Billion by 2031: Visiongain Research Inc

Visiongain has published a global macular degeneration (AMD) and other retinal diseases drugs market report 2021-2031.Forecasts By Indication (diabetic macular edema, diabetic retinopathy, retinal...